Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001707843 | SCV000732531 | likely benign | not provided | 2019-02-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000866293 | SCV001007370 | benign | Long QT syndrome | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002385954 | SCV002673579 | likely benign | Cardiovascular phenotype | 2020-10-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002491305 | SCV002802207 | likely benign | Long QT syndrome 13; Familial hyperaldosteronism type III | 2021-08-13 | criteria provided, single submitter | clinical testing |